Sun Pharma Advanced Research Company Limited
NSE: SPARC.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Anilkumar Raghavan
- Employees
- 409
- Headquarters
- Mumbai, India
- IPO year
- 2003
- Market cap
- ₹56.2B
- Website
- https://www.sparc.life
Loading SPARC…
Loading profile data…Frequently asked questions about SPARC
What does Sun Pharma Advanced Research Company Limited (SPARC.NS) do?
Sun Pharma Advanced Research Company Limited, a biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops new chemical and biological entities, and reformulated products with a therapeutic focus on oncology, neurodegeneration, ophthalmology, and dermatology. The compan...
Where does SPARC.NS trade?
Sun Pharma Advanced Research Company Limited (SPARC.NS) trades on the National Stock Exchange of India.
What sector is SPARC.NS in?
Sun Pharma Advanced Research Company Limited (SPARC.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Sun Pharma Advanced Research Company Limited?
Anilkumar Raghavan is the chief executive officer of Sun Pharma Advanced Research Company Limited (SPARC.NS).
Where is Sun Pharma Advanced Research Company Limited headquartered?
Sun Pharma Advanced Research Company Limited is headquartered in India.
Does SPARC.NS pay a dividend?
Sun Pharma Advanced Research Company Limited (SPARC.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SPARC.NS go public?
Sun Pharma Advanced Research Company Limited (SPARC.NS) completed its initial public offering in 2003.